The significance of this association is emphasized by the fact that a mutation in this region of Orc6, which has been linked to the onset of Meier-Gorlin syndrome, abrogates formation of fully intact ORC hexamers, suggesting a molecular mechanism for reduced origin licensing in this subset of MGS patients. The gene discussed is ORC6; the disease is Meier-Gorlin syndrome.